Could Your Address Determine Your Dementia Risk?
By Dennis Thompson HealthDay Reporter
MONDAY, June 30, 2025 — Your address might influence your risk for dementia, a new study says.
People living in poor neighborhoods appear to be more likely to have biological risk factors for inflammation and Alzheimer’s disease, researchers reported June 25 in the journal Neurology.
“These results suggest that neighborhood disadvantage increases the risk of inflammation, which may play an early role in the development of Alzheimer’s disease, as well as biomarkers for the disease itself,” senior researcher Angela Jefferson said in a news release. She’s director of the Memory and Alzheimer's Center at Vanderbilt University Medical Center in Nashville, Tenn.
For the study, researchers tracked 334 people with an average age of 73 for up to nine years, taking blood tests, brain scans and thinking and memory evaluations at regular intervals. About 180 people from the group also had samples of spinal fluid drawn.
People who lived in areas with greater neighborhood disadvantage — lower employment, less income, less education, more disability — were more likely to have elevated levels of tau, results showed.
Tau is a protein related to Alzheimer’s disease, researchers noted. The brains of people with advanced Alzheimer’s frequently feature toxic tau tangles.
“This observation suggests that living in more disadvantaged neighborhoods may result in more stressful exposures that drive neurodegeneration, resulting in an increased risk for developing Alzheimer's disease,” Jefferson said.
Further, the spinal fluid of participants had elevated levels of a biomarker related to inflammation, researchers found.
Greater neighborhood disadvantage was related to faster increases in levels of high sensitivity C-reactive protein (CRP), a well-established marker for inflammation, results showed.
The more disadvantage a neighborhood had, the higher residents’ CRP levels increased year-by-year, researchers reported.
“Based on these results, healthcare providers may consider neighborhood disadvantage when they are working with people who could benefit from strategies to reduce inflammation levels through lifestyle interventions, such as stress reduction techniques and exercise,” Jefferson said.
These results could be driven by the toxic stress faced by people struggling to get by, researchers said. This stress could increase inflammation, which in turn causes tau proteins to turn toxic.
“Continued efforts should also be made to include people who live in disadvantaged neighborhoods in studies on prevention and treatment of Alzheimer’s disease,” Jefferson added.
However, researchers noted that this study cannot prove a direct cause-and-effect link between poverty and dementia, only an association.
Sources
- American Academy of Neurology, news release, June 25, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Trump Administration May Cut Funds to Hospitals Offering Gender Care to Kids
TUESDAY, July 1, 2025 — The Trump administration may cut off federal funding to hospitals that provide gender-related treatments to children and teens. Nine major...
Supreme Court Won’t Hear Anti-Vaccine Group’s Free Speech Case
TUESDAY, July 1, 2025 — On Monday, the U.S. Supreme Court said it will not hear a case brought by a group once led by U.S. Health Secretary Robert F. Kennedy Jr. that...
Grip Provides Insight Into Psychosis, Study Says
TUESDAY, July 1, 2025 — “Get a grip” might be a truer saying for holding onto sanity than previously thought, a new study says. A loss of grip strength might be...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.